目的:研究替换CⅡ263-272序列中的268~270位氨基酸的变构肽sub268-270对胶原性关节炎(CIA)的抑制作用。方法:使用牛CⅡ在Lewis大鼠诱发CIA。以CⅡ变构肽sub268-270 90μg静脉注射,每周1次治疗CIA;设置无关肽对照和空白对照组。从关节炎症积分、放射学积分和病理学积分来评价变构肽疗效。结果:变构肽、无关肽及空白对照组关节炎症积分分别为5.60±1.24、11.20±1.21和11.80±1.22,变构肽可明显抑制CIA关节炎症(P〈0.01)。变构肽组的放射学积分(1.32±0.49)明显低于无关肽组(2.63±0.51)和空白对照组(2.69±0.53)(P〈0.01)。此外,变构肽组的病理学积分(1.37±0.53)也显著低于无关肽组(2.94±0.63)和空白对照组(3.06±0.65)(P〈0.01)。结论:CⅡ变构肽sub268-270可以明显抑制胶原性关节炎的关节炎症、病理损伤及骨破坏程度。
Objective:To study the inhibition of collagen-induced arthritis by an altered C Ⅱ 263-272 peptide (sub268-270) with three consecutive substitutions of TCR-contacting residues. Methods: Arthritis was induced by bovine collagen type Ⅱ. The altered peptide sub268-270 was given intravenously with a dose of 90 μg once a week. Peptide control and blank control were treated with similar approaches. The therapeutic effect of the altered peptide was evaluated by arthritis score index, radiological score and pathological score. Results :The arthritis score of rats treated with altered peptide, control peptide and blank control were 5.60 ± 1.24, 11.20 ± 1.21 and 11.80 ± 1.22 respectively( P 〈 0. 01 ), implying that the altered C Ⅱ peptide could decrease arthritis score of CIA. The radiological score of rats treated with altered peptide, control peptide and blank control were 1.32 ± 0. 49, 2. 63 ± 0. 51 and 2. 69 ± 0. 53 (P 〈0. 01 ) , showing that the altered C Ⅱ peptide could decrease CIA radiological lesions. The pathological score of rats treated with altered peptide, control peptide and blank control were 1.37 ± 0. 53, 2. 94 ± 0. 63 and 3. 06±0. 65 ( P 〈 0. 01 ), suggesting that the altered C Ⅱ peptide could retard CIA pathological injury. Concluslon:Altered C Ⅱ peptide sub268-270 could effectively ameliorate arthritis in CIA.